AroraS BalasubramaniamS ZhangW ZhangL SridharaR SpillmanD et al. Fda approval summary: Pembrolizumab plus lenvatinib for endometrial carcinoma, a collaborative international review under project orbis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results